姓 名 | 耿劲松 | 性别 | 女 | 专业技术职称 | 教授 |
学科专业 | 医学信息学 | 单 位 | 南通大学医学院医学信息学系 | ||
电子邮箱 | gjs@ntu.edu.cn | 联系电话(办公) | 0513-85051891 | ||
个人简历 | 博士研究生毕业于复旦大学国家卫生健康委卫生技术评估重点实验室。现担任中国医药生物技术协会卫生技术评估专业委员会委员、中国医疗保健国际交流促进会循证医学分会委员、国内外等多本学术期刊审稿人。哈佛大学医学院“Research Fellow in Health Policy and Insurance Research”,美国智库兰德公司访问学者。近年主持国家自然科学基金青年项目、教育部人文社会科学研究规划基金、国家卫生健康委卫生技术评估重点实验室开放基金、南通市社会民生面上项目等多项科研项目。主持江苏省高校首批一流本科课程《循证医学》,共同主编“十三五”江苏省高校重点教材《循证医学基础与实践》(科学出版社)。 | ||||
研究领域 | 医学信息资源利用与服务、循证医疗决策 | ||||
代表性成果(论文、专著、专利等) | Geng JS, Chen XW, Shi JW, Bao H, Chen Q, Yu H. Assessment of the satisfaction with public health insurance programs by patients with chronic diseases in China: a structural equation modeling approach. BMC Public Health, 2021, 21(1):1886 Geng JS, Bao HN, Feng Z, Meng JY, Yu XL, Yu H. Investigating patients' preferences for new anti-diabetic drugs to inform public health insurance coverage decisions: a discrete choice experiment in China. BMC Public Health, 2022, 22(1):1860 Yu XL, Bao HN, Shi JW, Yuan XY, Qian LL, Feng Z,Geng JS(通讯作者). Preferences for healthcare services among hypertension patients in China: a discrete choice experiment. BMJ Open, 2021, 11(12):e053270 Geng JS, Chen XW, Bao HN, Qian DM, Shao YT, Yu H. Patients’ preferences for health insurance coverage of new technologies for treating chronic diseases in China: a discrete choice experiment. BMJ Open, 2020,10(9):e038051. Geng JS, Bao HN, Chen YL, Shi LL, Geng J, Wang Q, Yu H. Nucleos(t)ide analogues for the treatment of chronic hepatitis B: a systematic review with network meta-analysis. Expert Rev Anti Infect Ther, 2020,18(8):823-834 Geng JS, Yu XL, Bao HN, Feng Z, Yuan XY, Zhang JY, Chen XW, Chen YL, Li CL, Yu H. Chronic diseases as a predictor for severity and mortality of COVID-19: a systematic review with cumulative meta-analysis. Front Med, 2021, 8:588013 Geng JS, Dong JC, Li YP,Ni HJ, Jiang K, Shi LL, Wang GH. Intravenous immunoglobulins for epilepsy. Cochrane Database Syst Rev, 2019, 12(12):CD008557 |